Posts Tagged ‘ Judge Joseph Goodwin ’

C.R. Bard Transvaginal Mesh Trial Continued – The Final Case in this Bellwether

Jan 9th, 2014 | By
C.R. Bard Transvaginal Mesh Trial Continued – The Final Case in this Bellwether

This will be the third time the case of Carolyn Jones v. C.R. Bard has had a trial date moved in the federal litigation taking place in a courthouse in Charleston, West Virginia. Each of six manufacturers will face four bellwether trials agreed to by both the defense and plaintiffs.  In this case, Carolyn Jones,
[continue reading...]



Mesh Lawsuits Filed: Ten-Thousand and Growing

Oct 17th, 2012 | By
Mesh Lawsuits Filed: Ten-Thousand and Growing

  October 17, 2012 ~ Court cases filed around the country naming six mesh makers currently number 10,000 and are growing, some at a rate of 100 new cases filed a week. MDND has added up the number of lawsuits pending in federal court consolidated in multidistrict litigation (MDL) as well as those cases filed
[continue reading...]



Lead Attorneys to be Chosen in Transvaginal Mesh Cases Friday, April 13

Apr 12th, 2012 | By
Lead Attorneys to be Chosen in Transvaginal Mesh Cases Friday, April 13

The Honorable Judge Joseph Goodwin will oversee a hearing Friday, April 13, to decide who will be the lead attorneys in the consolidated lawsuits over defective transvaginal mesh. Hundreds of cases have been consolidated in the Southern District of West Virginia in Multidistrict litigation (MDL) that name mesh manufacturers Ethicon, Inc ( MDL No. 2327),
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.